These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 34377733)

  • 1. SARS-CoV-2 Cumulative Incidence and Period Seroprevalence: Results From a Statewide Population-Based Serosurvey in California.
    Lamba K; Bradley H; Shioda K; Sullivan PS; Luisi N; Hall EW; Mehrotra ML; Lim E; Jain S; Kamali A; Sanchez T; Lopman BA; Fahimi M; Siegler AJ
    Open Forum Infect Dis; 2021 Aug; 8(8):ofab379. PubMed ID: 34377733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cumulative Incidence of SARS-CoV-2 Infections Among Adults in Georgia, United States, August to December 2020.
    Chamberlain AT; Toomey KE; Bradley H; Hall EW; Fahimi M; Lopman BA; Luisi N; Sanchez T; Drenzek C; Shioda K; Siegler AJ; Sullivan PS
    J Infect Dis; 2022 Feb; 225(3):396-403. PubMed ID: 34662409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe Acute Respiratory Syndrome Coronavirus 2 Cumulative Incidence, United States, August 2020-December 2020.
    Sullivan PS; Siegler AJ; Shioda K; Hall EW; Bradley H; Sanchez T; Luisi N; Valentine-Graves M; Nelson KN; Fahimi M; Kamali A; Sailey C; Lopman BA
    Clin Infect Dis; 2022 Apr; 74(7):1141-1150. PubMed ID: 34245245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimating the Cumulative Incidence of SARS-CoV-2 Infection and the Infection Fatality Ratio in Light of Waning Antibodies.
    Shioda K; Lau MSY; Kraay ANM; Nelson KN; Siegler AJ; Sullivan PS; Collins MH; Weitz JS; Lopman BA
    Epidemiology; 2021 Jul; 32(4):518-524. PubMed ID: 33935138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2 antibody seroprevalence in India, August-September, 2020: findings from the second nationwide household serosurvey.
    Murhekar MV; Bhatnagar T; Selvaraju S; Saravanakumar V; Thangaraj JWV; Shah N; Kumar MS; Rade K; Sabarinathan R; Asthana S; Balachandar R; Bangar SD; Bansal AK; Bhat J; Chopra V; Das D; Deb AK; Devi KR; Dwivedi GR; Khan SMS; Kumar CPG; Kumar MS; Laxmaiah A; Madhukar M; Mahapatra A; Mohanty SS; Rangaraju C; Turuk A; Baradwaj DK; Chahal AS; Debnath F; Haq I; Kalliath A; Kanungo S; Kshatri JS; Lakshmi GGJN; Mitra A; Nirmala AR; Prasad GV; Qurieshi MA; Sahay S; Sangwan RK; Sekar K; Shukla VK; Singh PK; Singh P; Singh R; Varma DS; Viramgami A; Panda S; Reddy DCS; Bhargava B;
    Lancet Glob Health; 2021 Mar; 9(3):e257-e266. PubMed ID: 33515512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of SARS-CoV-2 infection in India: Findings from the national serosurvey, May-June 2020.
    Murhekar MV; Bhatnagar T; Selvaraju S; Rade K; Saravanakumar V; Vivian Thangaraj JW; Kumar MS; Shah N; Sabarinathan R; Turuk A; Anand PK; Asthana S; Balachandar R; Bangar SD; Bansal AK; Bhat J; Chakraborty D; Rangaraju C; Chopra V; Das D; Deb AK; Devi KR; Dwivedi GR; Salim Khan SM; Haq I; Kumar MS; Laxmaiah A; Madhuka ; Mahapatra A; Mitra A; Nirmala AR; Pagdhune A; Qurieshi MA; Ramarao T; Sahay S; Sharma YK; Shrinivasa MB; Shukla VK; Singh PK; Viramgami A; Wilson VC; Yadav R; Girish Kumar CP; Luke HE; Ranganathan UD; Babu S; Sekar K; Yadav PD; Sapkal GN; Das A; Das P; Dutta S; Hemalatha R; Kumar A; Narain K; Narasimhaiah S; Panda S; Pati S; Patil S; Sarkar K; Singh S; Kant R; Tripathy S; Toteja GS; Babu GR; Kant S; Muliyil JP; Pandey RM; Sarkar S; Singh SK; Zodpey S; Gangakhedkar RR; S Reddy DC; Bhargava B
    Indian J Med Res; 2020 Jul & Aug; 152(1 & 2):48-60. PubMed ID: 32952144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimation of US SARS-CoV-2 Infections, Symptomatic Infections, Hospitalizations, and Deaths Using Seroprevalence Surveys.
    Angulo FJ; Finelli L; Swerdlow DL
    JAMA Netw Open; 2021 Jan; 4(1):e2033706. PubMed ID: 33399860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimating the cumulative incidence of SARS-CoV-2 infection and the infection fatality ratio in light of waning antibodies.
    Shioda K; Lau MS; Kraay AN; Nelson KN; Siegler AJ; Sullivan PS; Collins MH; Weitz JS; Lopman BA
    medRxiv; 2020 Nov; ():. PubMed ID: 33236035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence and Reported Coronavirus Disease 2019 Cases in US Children, August 2020-May 2021.
    Couture A; Lyons BC; Mehrotra ML; Sosa L; Ezike N; Ahmed FS; Brown CM; Yendell S; Azzam IA; Katić BJ; Cope A; Dickerson K; Stone J; Traxler LB; Dunn JR; Davis LB; Reed C; Clarke KEN; Flannery B; Charles MD
    Open Forum Infect Dis; 2022 Mar; 9(3):ofac044. PubMed ID: 35198651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimated SARS-CoV-2 infection rate and fatality risk in Gauteng Province, South Africa: a population-based seroepidemiological survey.
    Mutevedzi PC; Kawonga M; Kwatra G; Moultrie A; Baillie V; Mabena N; Mathibe MN; Rafuma MM; Maposa I; Abbott G; Hugo J; Ikalafeng B; Adelekan T; Lukhele M; Madhi SA
    Int J Epidemiol; 2022 May; 51(2):404-417. PubMed ID: 34718591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in seroprevalence of SARS-CoV-2 and infection fatality rate in the Norwegian population through the first year of the COVID-19 pandemic.
    Tunheim G; Rø GØI; Tran T; Kran AB; Andersen JT; Vaage EB; Kolderup A; Vaage JT; Lund-Johansen F; Hungnes O
    Influenza Other Respir Viruses; 2022 Mar; 16(2):204-212. PubMed ID: 34751488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of US Blood Donors for National Serosurveillance of Severe Acute Respiratory Syndrome Coronavirus 2 Antibodies: Basis for an Expanded National Donor Serosurveillance Program.
    Stone M; Di Germanio C; Wright DJ; Sulaeman H; Dave H; Fink RV; Notari EP; Green V; Strauss D; Kessler D; Destree M; Saa P; Williamson PC; Simmons G; Stramer SL; Opsomer J; Jones JM; Kleinman S; Busch MP;
    Clin Infect Dis; 2022 Mar; 74(5):871-881. PubMed ID: 34111244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global seroprevalence of SARS-CoV-2 antibodies: A systematic review and meta-analysis.
    Bobrovitz N; Arora RK; Cao C; Boucher E; Liu M; Donnici C; Yanes-Lane M; Whelan M; Perlman-Arrow S; Chen J; Rahim H; Ilincic N; Segal M; Duarte N; Van Wyk J; Yan T; Atmaja A; Rocco S; Joseph A; Penny L; Clifton DA; Williamson T; Yansouni CP; Evans TG; Chevrier J; Papenburg J; Cheng MP
    PLoS One; 2021; 16(6):e0252617. PubMed ID: 34161316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Based on Blood Donations, July 2020-May 2021.
    Jones JM; Stone M; Sulaeman H; Fink RV; Dave H; Levy ME; Di Germanio C; Green V; Notari E; Saa P; Biggerstaff BJ; Strauss D; Kessler D; Vassallo R; Reik R; Rossmann S; Destree M; Nguyen KA; Sayers M; Lough C; Bougie DW; Ritter M; Latoni G; Weales B; Sime S; Gorlin J; Brown NE; Gould CV; Berney K; Benoit TJ; Miller MJ; Freeman D; Kartik D; Fry AM; Azziz-Baumgartner E; Hall AJ; MacNeil A; Gundlapalli AV; Basavaraju SV; Gerber SI; Patton ME; Custer B; Williamson P; Simmons G; Thornburg NJ; Kleinman S; Stramer SL; Opsomer J; Busch MP
    JAMA; 2021 Oct; 326(14):1400-1409. PubMed ID: 34473201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimated Community Seroprevalence of SARS-CoV-2 Antibodies - Two Georgia Counties, April 28-May 3, 2020.
    Biggs HM; Harris JB; Breakwell L; Dahlgren FS; Abedi GR; Szablewski CM; Drobeniuc J; Bustamante ND; Almendares O; Schnall AH; Gilani Z; Smith T; Gieraltowski L; Johnson JA; Bajema KL; McDavid K; Schafer IJ; Sullivan V; Punkova L; Tejada-Strop A; Amiling R; Mattison CP; Cortese MM; Ford SE; Paxton LA; Drenzek C; Tate JE;
    MMWR Morb Mortal Wkly Rep; 2020 Jul; 69(29):965-970. PubMed ID: 32701941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cumulative incidence and diagnosis of SARS-CoV-2 infection in New York.
    Rosenberg ES; Tesoriero JM; Rosenthal EM; Chung R; Barranco MA; Styer LM; Parker MM; John Leung SY; Morne JE; Greene D; Holtgrave DR; Hoefer D; Kumar J; Udo T; Hutton B; Zucker HA
    Ann Epidemiol; 2020 Aug; 48():23-29.e4. PubMed ID: 32648546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population Point Prevalence of SARS-CoV-2 Infection Based on a Statewide Random Sample - Indiana, April 25-29, 2020.
    Menachemi N; Yiannoutsos CT; Dixon BE; Duszynski TJ; Fadel WF; Wools-Kaloustian KK; Unruh Needleman N; Box K; Caine V; Norwood C; Weaver L; Halverson PK
    MMWR Morb Mortal Wkly Rep; 2020 Jul; 69(29):960-964. PubMed ID: 32701938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Seroprevalence in Massachusetts Estimated from Newborn Screening Specimens.
    Ma KC; Hale JE; Grad YH; Alter G; Luzuriaga K; Eaton RB; Fischinger S; Kaur D; Brody R; Siddiqui SM; Leach D; Brown CM; Klevens RM; Madoff L; Comeau AM
    Clin Infect Dis; 2022 Aug; 75(1):e105-e113. PubMed ID: 35213690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of Seroprevalence of SARS-CoV-2 and Risk Factors Associated With COVID-19 Infection Among Outpatients in Virginia.
    Rogawski McQuade ET; Guertin KA; Becker L; Operario D; Gratz J; Guan D; Khan F; White J; McMurry TL; Shah B; Garofalo S; Southerland M; Bear K; Brush J; Allen C; Frayser A; Vokes R; Pershad R; Peake L; deFilippi C; Barackman K; Bearman G; Bidanset A; Farrell F; Trump D; Houpt ER
    JAMA Netw Open; 2021 Feb; 4(2):e2035234. PubMed ID: 33555331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2 antibody seroprevalence in Lebanon: findings from the first nationwide serosurvey.
    Hoballah A; El Haidari R; Siblany G; Abdel Sater F; Mansour S; Hassan H; Abou-Abbas L
    BMC Infect Dis; 2022 Jan; 22(1):42. PubMed ID: 35012464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.